Promoter-wide analysis of Smad4 binding sites in human epithelial cells.
Smad4, the common partner Smad, is a key molecule in transforming growth factor-beta (TGF-beta) family signaling. Loss of Smad4 expression is found in several types of cancer, including pancreatic cancer and colon cancer, and is related to carcinogenesis. Here we identified Smad4 binding sites in the promoter regions of over 25 500 known genes by chromatin immunoprecipitation on a microarray (ChIP-chip) in HaCaT human keratinocytes. We identified 925 significant Smad4 binding sites. Approximately half of the identified sites overlapped the binding regions of Smad2 and Smad3 (Smad2/3, receptor-regulated Smads in TGF-beta signaling), while the rest of the regions appeared dominantly occupied by Smad4 even when a different identification threshold for Smad2/3 binding regions was used. Distribution analysis showed that Smad4 was found in the regions relatively distant from the transcription start sites, while Smad2/3 binding regions were more often present near the transcription start sites. Motif analysis also revealed that activator protein 1 (AP-1) sites were especially enriched in the sites common to Smad2/3 and Smad4 binding regions. In contrast, GC-rich motifs were enriched in Smad4-dominant binding regions. We further determined putative target genes of Smad4 whose expression was regulated by TGF-beta. Our findings revealed some general characteristics of Smad4 binding regions, and provide resources for examining the role of Smad4 in epithelial cells and cancer pathogenesis.
Koinuma
Daizo
D
Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo.
Tsutsumi
Shuichi
S
Kamimura
Naoko
N
Imamura
Takeshi
T
Aburatani
Hiroyuki
H
Miyazono
Kohei
K
D001665:Binding Sites; D002478:Cells, Cultured; D047369:Chromatin Immunoprecipitation; D004847:Epithelial Cells / Q000378:metabolism*; D006801:Humans; D011401:Promoter Regions, Genetic; D015398:Signal Transduction; D051899:Smad2 Protein / Q000378:metabolism; D051900:Smad3 Protein / Q000378:metabolism; D051901:Smad4 Protein / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000494:pharmacology
C497782:SMAD2 protein, human; C497790:SMAD3 protein, human; C497796:SMAD4 protein, human; D051899:Smad2 Protein; D051900:Smad3 Protein; D051901:Smad4 Protein; D016212:Transforming Growth Factor beta
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W551-4
16845068
J Cell Biol. 1988 Mar;106(3):761-71
2450098
Genomics. 2007 Feb;89(2):178-88
17085012
Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):41-58
16310402
Cancer Sci. 2005 Nov;96(11):791-800
16271073
Genome Res. 2004 Jun;14(6):1188-90
15173120
Mol Cell Biol. 2009 Jan;29(1):172-86
18955504
Oncogene. 2006 Jan 12;25(2):207-17
16170355
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10315-9
7694291
Cancer Res. 2007 Oct 15;67(20):9694-703
17942899
Nat Chem Biol. 2008 Jan;4(1):33-41
18026094
EMBO J. 2003 Dec 15;22(24):6458-70
14657019
Oncogene. 2002 Mar 7;21(11):1777-84
11896609
Mol Cell Biol. 2005 Sep;25(18):8108-25
16135802
Oncogene. 2005 Jan 20;24(4):662-71
15592526
Cell. 2003 Jun 13;113(6):685-700
12809600
Nat Genet. 2001 Oct;29(2):117-29
11586292
Cancer Res. 2005 Oct 1;65(19):8671-8
16204035
Genes Cells. 2002 Dec;7(12):1191-204
12485160
EMBO J. 2002 Apr 2;21(7):1743-53
11927558
Science. 1996 Jan 19;271(5247):350-3
8553070
Blood. 2007 Mar 1;109(5):1953-61
17068149
Nature. 1998 Aug 27;394(6696):909-13
9732876
J Clin Invest. 2008 Aug;118(8):2722-32
18618014
Nature. 1993 Apr 1;362(6419):462-5
8464478
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2487-92
18268325
Genes Dev. 2006 Nov 15;20(22):3130-46
17114584
Nature. 1997 Dec 4;390(6659):465-71
9393997
Nature. 2008 Feb 14;451(7180):796-801
18235444
Mol Cell Biol. 2008 Nov;28(22):6889-902
18794361
EMBO J. 2009 Jan 21;28(2):88-98
19096363
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12457-62
16895995